180 Degree Capital Corp Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/27/2025)
| Balance Sheet | Total Assets | 47,610,100.00 | ROE | – |
| Balance Sheet | Total Equity | 46,352,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -1.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 269,932.00 | – | – |
| Cashflow | Operating Cash Flow | 269,933.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -0.38 | Div. Yield | – |
| Income | Net Income | -3,866,160.00 | P/E | – |
| Income | Shares Outstanding | 10,174,100.00 | P/B | – |
| Income | Total Revenue | 348,341.00 | P/S | – |
Ratios calculated on: –
Company Description
Harris & Harris Group, Inc., is an internally managed venture capital company specializing in nanotechnology and Microsystems. The Company´s investment objective is to achieve long-term capital appreciation by making venture capital investments. The Company generally makes venture capital investments exclusively in companies commercializing or integrating products enabled by nanotechnology or microsystems. Nanotechnology is measured in nanometers, which are units of measurement in billionths of a meter. As of December 31, 2011, the Company´s venture capital portfolio comprised 75.2 %of its total assets, its cash comprised 22.5 % of its total assets, and other assets comprised the remaining 2.3 %of its total assets. In July 2013, Harris and Harris Group Inc announced the closing of the sale of Xradia to Carl Zeiss.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.hhvc.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more